Pakistan, Oct. 23 -- The widely used COVID-19 vaccines may do more than prevent infections - they could also help cancer patients fight tumors more effectively. Researchers discovered that mRNA vaccines, such as Pfizer and Moderna, might enhance the immune response in patients undergoing immunotherapy. This surprising link suggests that these vaccines could potentially improve survival rates among those battling advanced lung or skin cancer.

Scientists from the MD Anderson Cancer Center and the University of Florida found that cancer patients who received an mRNA vaccine within 100 days of starting immunotherapy lived notably longer than those who didn't. Interestingly, the benefit wasn't related to protection against the virus but rathe...